Provided by Tiger Trade Technology Pte. Ltd.

Nurix Therapeutics

14.67
-0.0900-0.61%
Post-market: 14.670.00000.00%16:10 EDT
Volume:1.04M
Turnover:15.19M
Market Cap:1.51B
PE:-4.81
High:15.01
Open:14.77
Low:14.41
Close:14.76
52wk High:22.50
52wk Low:8.18
Shares:102.84M
Float Shares:86.36M
Volume Ratio:0.80
T/O Rate:1.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0514
EPS(LYR):-3.0514
ROE:-49.63%
ROA:-26.30%
PB:2.80
PE(LYR):-4.81

Loading ...

Jun 01, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Major Issues Report

8-K - Current report
Apr 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 13, 2021

Major Issues Report

8-K - Current report
Mar 02, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 02, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 02, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 04, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 07, 2020

Major Issues Report

8-K - Current report
Oct 26, 2020

Major Issues Report

8-K - Current report
Oct 14, 2020

Major Issues Report

8-K - Current report
Oct 14, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 14, 2020

Major Issues Report

8-K - Current report